Churchwell to depart VHVI; Clair to assume interim role

Keith Churchwell, M.D., executive director and chief medical officer for the Vanderbilt Heart and Vascular Institute (VHVI), is departing Vanderbilt and will join Yale-New Haven Health System as vice president and executive director of Cardiovascular Services on Dec. 1.

Heart Institute testing world’s tiniest pacemaker

Vanderbilt Heart and Vascular Institute is participating in a global clinical trial to test the safety and efficacy of the world’s smallest pacemaker.

Team effort key to ease patient’s rare heart disorder

Vanderbilt employee Drew Casey, 27, was at home when he began to experience shortness of breath. Thinking it might be a panic attack, his wife, Katie, called 911, and an ambulance took Casey to the Emergency Department, where he progressed very suddenly to circulatory failure and shock.

Photo: Vanderbilt Heart Town Hall

VHVI educates airport screeners on heart devices

Thanks to advances in technology, heart patients with ventricular assist devices (VADs) are able to travel with greater frequency.

New heart pump allows minimally invasive approach

Sometimes smaller is better. This is especially true of left ventricular assist devices, the mechanically operated heart pumps that are implanted in heart failure patients to bridge them to transplantation.